XSHC.L vs. BTEC.L
XSHC.L (Xtrackers MSCI USA Health Care UCITS ETF 1D) and BTEC.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) are both Health & Biotech Equities funds - XSHC.L tracks the MSCI World/Health Care NR USD while BTEC.L tracks the NASDAQ Biotechnology NET Index. Both are passively managed. Over the past 5 years, XSHC.L returned 5.82%/yr vs 6.09%/yr for BTEC.L. A 0.66 correlation means they provide meaningful diversification when combined. XSHC.L charges 0.12%/yr vs 0.35%/yr for BTEC.L.
Performance
XSHC.L vs. BTEC.L - Performance Comparison
Loading charts...
Different Trading Currencies
XSHC.L is traded in GBp, while BTEC.L is traded in USD. To make them comparable, the BTEC.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, XSHC.L achieves a 2.07% return, which is significantly lower than BTEC.L's 13.97% return.
XSHC.L
- 1D
- -0.30%
- 1M
- 3.82%
- 6M
- 1.23%
- YTD
- 2.07%
- 1Y
- 19.69%
- 3Y*
- 6.92%
- 5Y*
- 5.82%
- 10Y*
- —
BTEC.L
- 1D
- 0.00%
- 1M
- 7.86%
- 6M
- 11.73%
- YTD
- 13.97%
- 1Y
- 47.71%
- 3Y*
- 15.40%
- 5Y*
- 6.09%
- 10Y*
- —
XSHC.L vs. BTEC.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
XSHC.L Xtrackers MSCI USA Health Care UCITS ETF 1D | 2.07% | 6.84% | 4.08% | -3.58% | 8.14% | 28.13% | 9.97% | 16.71% | 14.71% |
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | 13.97% | 23.49% | -0.33% | 0.91% | -1.44% | 0.45% | 23.66% | 20.79% | 0.18% |
Correlation
The correlation between XSHC.L and BTEC.L is 0.66, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.66 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.59 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.61 |
Correlation (All Time) Calculated using the full available price history since Apr 23, 2018 | 0.66 |
The correlation between XSHC.L and BTEC.L has been stable across timeframes, ranging from 0.59 to 0.66 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XSHC.L vs. BTEC.L — Risk / Return Rank
XSHC.L
BTEC.L
XSHC.L vs. BTEC.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI USA Health Care UCITS ETF 1D (XSHC.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XSHC.L | BTEC.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.01 | ||
| Sortino ratioReturn per unit of downside risk | -1.17 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.37 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.60 | 6.45 | -4.84 |
| Martin ratioReturn relative to average drawdown | 3.91 | 18.57 | -14.65 |
Loading charts...
Drawdowns
XSHC.L vs. BTEC.L - Drawdown Comparison
The maximum XSHC.L drawdown since its inception was -19.16%, smaller than the maximum BTEC.L drawdown of -31.02%. Use the drawdown chart below to compare losses from any high point for XSHC.L and BTEC.L.
Loading charts...
Drawdown Indicators
| XSHC.L | BTEC.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -19.16% | -31.02% | +11.86% |
Max Drawdown (1Y)Largest decline over 1 year | -12.22% | -7.31% | -4.91% |
Max Drawdown (3Y)Largest decline over 3 years | -19.16% | -26.37% | +7.21% |
Max Drawdown (5Y)Largest decline over 5 years | -19.16% | -31.02% | +11.86% |
Current DrawdownCurrent decline from peak | -4.30% | -5.72% | +1.42% |
Average DrawdownAverage peak-to-trough decline | -4.77% | -9.99% | +5.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.02% | 2.54% | +2.48% |
Volatility
XSHC.L vs. BTEC.L - Volatility Comparison
The current volatility for Xtrackers MSCI USA Health Care UCITS ETF 1D (XSHC.L) is 5.34%, while iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) has a volatility of 5.91%. This indicates that XSHC.L experiences smaller price fluctuations and is considered to be less risky than BTEC.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XSHC.L | BTEC.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.34% | 5.91% | -0.57% |
Volatility (6M)Calculated over the trailing 6-month period | 10.99% | 15.31% | -4.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.18% | 20.42% | -5.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.38% | 20.98% | -6.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.76% | 22.30% | -6.54% |
XSHC.L vs. BTEC.L - Expense Ratio Comparison
XSHC.L has a 0.12% expense ratio, which is lower than BTEC.L's 0.35% expense ratio.
Dividends
XSHC.L vs. BTEC.L - Dividend Comparison
XSHC.L's dividend yield for the trailing twelve months is around 1.23%, while BTEC.L has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XSHC.L Xtrackers MSCI USA Health Care UCITS ETF 1D | 1.23% | 1.25% | 1.24% | 1.23% | 1.55% | 0.85% | 1.12% | 0.98% |
Frequently Asked Questions
XSHC.L and BTEC.L have a correlation of 0.66, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XSHC.L is cheaper at 0.12% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XSHC.L is cheaper with a 0.12% expense ratio, compared with 0.35% for BTEC.L.
XSHC.L tracks MSCI World/Health Care NR USD, while BTEC.L tracks NASDAQ Biotechnology NET Index. They also come from different issuers: Xtrackers and iShares. Their fees differ too: 0.12% for XSHC.L and 0.35% for BTEC.L.
Find the right allocation for XSHC.L and BTEC.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer